C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China's MAH Framework

On June 23, 2026, C-Ray Therapeutics (Chengdu) Co., Ltd. (C-Ray Therapeutics) completed on-site inspections conducted by a ...
Yahoo Finance

C-Ray Therapeutics and SHINE Technologies Enter Strategic Partnership for Exclusive Distribution of No-Carrier-Added Lu-177 in Mainland China

CHENGDU, China and JANESVILLE, Wis., March 26, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu, China), a global radiopharmaceutical CRDMO, today announced the execution of a Master Radioisotope ...
Yahoo Finance

C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025

BARCELONA, Spain, Oct. 8, 2025 /PRNewswire/ -- During the 2025 Annual Congress of the European Association of Nuclear Medicine (EANM 2025), C-Ray Therapeutics (Shanghai) Co., Ltd. ("C-Ray Shanghai"), ...
Yahoo Finance

C-Ray Therapeutics Achieves AAALAC International Full Accreditation, Reinforcing Commitment to Excellence in Preclinical Research

CHENGDU, China, Feb. 24, 2026 /PRNewswire/ -- C-Ray Therapeutics, a global Contract Research, Development and Manufacturing Organization (CRDMO) specializing in radiopharmaceuticals, announced today ...
manilatimes

C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital

CHENGDU, China, Nov. 18, 2024 /PRNewswire/ -- In November 2024, C Ray Therapeutics (Chengdu) Co., Ltd. (hereinafter referred to as "C Ray"), an innovative enterprise in the field of ...
Yahoo Finance

C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001

CHENGDU, China, Oct. 11, 2025 /PRNewswire/ -- C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the National ...